OpenInsiders01Web Canada
SEC INSIDER TRANSACTIONS

TEXAS INSTRUMENTS INC (TXN) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

TXN · TEXAS INSTRUMENTS INC

How to read this data ↗
More transaction filters

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 14 filings · fetched 2026-11-13T20:20:13Z

Recent reported activity

0purchase rows on this page
10sale rows on this page
39matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filedReporting owner(s)Code / securityQuantityPrice as filedOwnershipSource
2026-10-29Filed 2026-10-30KIRK RONALDDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $309.92 to $310.81. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The option became exercisable in four equal annual installments beginning on January 26, 2018.

References: F2

M Exercise / conversionNQ Stock Option (Right to Buy) · Derivative6,065D0DirectForm 4 ↗0000097476-26-000178
2026-10-29Filed 2026-10-30KIRK RONALDDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $309.92 to $310.81. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The option became exercisable in four equal annual installments beginning on January 26, 2018.

References: F1

S Sale (market/private)Common Stock · Non-derivative6,065D310.39DirectForm 4 ↗0000097476-26-000178
2026-10-29Filed 2026-10-30KIRK RONALDDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $309.92 to $310.81. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The option became exercisable in four equal annual installments beginning on January 26, 2018.

References:

M Exercise / conversionCommon Stock · Non-derivative6,065A79.26DirectForm 4 ↗0000097476-26-000178
2026-10-27Filed 2026-10-29SANCHEZ ROBERT EDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.92 to $302.91. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.98 to $303.31. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The option became exercisable in four equal annual installments beginning on January 26, 2018.

References: F3

M Exercise / conversionNQ Stock Option (Right to Buy) · Derivative6,065D0DirectForm 4 ↗0000097476-26-000172
2026-10-27Filed 2026-10-29SANCHEZ ROBERT EDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.92 to $302.91. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.98 to $303.31. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The option became exercisable in four equal annual installments beginning on January 26, 2018.

References: F2

S Sale (market/private)Common Stock · Non-derivative477D303.07DirectForm 4 ↗0000097476-26-000172
2026-10-27Filed 2026-10-29SANCHEZ ROBERT EDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.92 to $302.91. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.98 to $303.31. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The option became exercisable in four equal annual installments beginning on January 26, 2018.

References: F1

S Sale (market/private)Common Stock · Non-derivative5,588D302.14DirectForm 4 ↗0000097476-26-000172
2026-10-27Filed 2026-10-29SANCHEZ ROBERT EDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.92 to $302.91. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.98 to $303.31. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The option became exercisable in four equal annual installments beginning on January 26, 2018.

References:

M Exercise / conversionCommon Stock · Non-derivative6,065A79.26DirectForm 4 ↗0000097476-26-000172
2026-10-27Filed 2026-10-29PATSLEY PAMELA HDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.35 to $301.88. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The option became exercisable in four equal annual installments beginning on January 25, 2020.

References: F2

M Exercise / conversionNQ Stock Option (Right to Buy) · Derivative4,532D0DirectForm 4 ↗0000097476-26-000174
2026-10-27Filed 2026-10-29PATSLEY PAMELA HDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.35 to $301.88. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The option became exercisable in four equal annual installments beginning on January 25, 2020.

References: F1

S Sale (market/private)Common Stock · Non-derivative4,532D301.56DirectForm 4 ↗0000097476-26-000174
2026-10-27Filed 2026-10-29PATSLEY PAMELA HDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $301.35 to $301.88. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The option became exercisable in four equal annual installments beginning on January 25, 2020.

References:

M Exercise / conversionCommon Stock · Non-derivative4,532A104.41DirectForm 4 ↗0000097476-26-000174
2026-10-27Filed 2026-10-29CLARK JANET FDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.11 to $303.01. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $303.13 to $303.24. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The option became exercisable in four equal annual installments beginning on January 25, 2019.

References: F3

M Exercise / conversionNQ Stock Option (Right to Buy) · Derivative4,306D0DirectForm 4 ↗0000097476-26-000176
2026-10-27Filed 2026-10-29CLARK JANET FDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.11 to $303.01. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $303.13 to $303.24. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The option became exercisable in four equal annual installments beginning on January 25, 2019.

References: F2

S Sale (market/private)Common Stock · Non-derivative350D303.17DirectForm 4 ↗0000097476-26-000176
2026-10-27Filed 2026-10-29CLARK JANET FDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.11 to $303.01. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $303.13 to $303.24. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The option became exercisable in four equal annual installments beginning on January 25, 2019.

References: F1

S Sale (market/private)Common Stock · Non-derivative3,956D302.4DirectForm 4 ↗0000097476-26-000176
2026-10-27Filed 2026-10-29CLARK JANET FDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.11 to $303.01. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $303.13 to $303.24. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The option became exercisable in four equal annual installments beginning on January 25, 2019.

References:

M Exercise / conversionCommon Stock · Non-derivative4,306A110.15DirectForm 4 ↗0000097476-26-000176
2026-09-18Filed 2026-09-21FARMER CURTIS CDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Security converts to common stock on a one-for-one basis.

F2 Stock units credited under the Texas Instruments 2018 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the 2018 Plan and the predecessor director compensation plan.

References: F1, F2

A Award / grantStock Units · Derivative106.53A258.14DirectForm 4 ↗0000097476-26-000161
2026-09-18Filed 2026-09-21PATSLEY PAMELA HDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Security converts to common stock on a one-for-one basis.

F2 Stock units credited under the Texas Instruments 2018 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the 2018 Plan and the predecessor director compensation plan.

References: F1, F2

A Award / grantStock Units · Derivative106.53A258.14DirectForm 4 ↗0000097476-26-000158
2026-08-27Filed 2026-08-31Abraham TsedeniyaOfficer · Sr. Vice President
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $264.16 to $264.98. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $264.83 to $265.03. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The stock option became exercisable in four equal annual installments beginning on January 26, 2018.

References: F3

M Exercise / conversionNQ Stock Option (Right to Buy) · Derivative1,365D0DirectForm 4 ↗0000097476-26-000156
2026-08-27Filed 2026-08-31Abraham TsedeniyaOfficer · Sr. Vice President
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $264.16 to $264.98. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $264.83 to $265.03. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The stock option became exercisable in four equal annual installments beginning on January 26, 2018.

References: F2

S Sale (market/private)Common Stock · Non-derivative592D264.96DirectForm 4 ↗0000097476-26-000156
2026-08-27Filed 2026-08-31Abraham TsedeniyaOfficer · Sr. Vice President
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $264.16 to $264.98. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $264.83 to $265.03. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The stock option became exercisable in four equal annual installments beginning on January 26, 2018.

References: F1

S Sale (market/private)Common Stock · Non-derivative6,408D264.6DirectForm 4 ↗0000097476-26-000156
2026-08-27Filed 2026-08-31Abraham TsedeniyaOfficer · Sr. Vice President
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $264.16 to $264.98. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $264.83 to $265.03. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3 The stock option became exercisable in four equal annual installments beginning on January 26, 2018.

References:

M Exercise / conversionCommon Stock · Non-derivative1,365A79.26DirectForm 4 ↗0000097476-26-000156
2026-07-24Filed 2026-07-31Knecht Julie C.Officer · VP & Chief Accounting Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Award of restricted stock units pursuant to 2024 Long-Term Incentive Plan.

References: F1

A Award / grantCommon Stock · Non-derivative7,154A0DirectForm 4 ↗0000097476-26-000154
2026-06-19Filed 2026-06-22FARMER CURTIS CDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Security converts to common stock on a one-for-one basis.

F2 Stock units credited under the Texas Instruments 2018 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the 2018 Plan and the predecessor director compensation plan.

References: F1, F2

A Award / grantStock Units · Derivative85.18A322.86DirectForm 4 ↗0000097476-26-000145
2026-06-19Filed 2026-06-22PATSLEY PAMELA HDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Security converts to common stock on a one-for-one basis.

F2 Stock units credited under the Texas Instruments 2018 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the 2018 Plan and the predecessor director compensation plan.

References: F1, F2

A Award / grantStock Units · Derivative85.18A322.86DirectForm 4 ↗0000097476-26-000144
2026-05-28Filed 2026-05-29Craighead Martin SDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $320.00 to $320.9867. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

References:

S Sale (market/private)Common Stock · Non-derivative357D321.0069DirectForm 4 ↗0001319699-26-000004
2026-05-28Filed 2026-05-29Craighead Martin SDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $320.00 to $320.9867. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

References: F1

S Sale (market/private)Common Stock · Non-derivative9,643D320.4075DirectForm 4 ↗0001319699-26-000004

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.